Abstract
Alzheimer’s disease (AD) is characterised by the presence of extracellular amyloid plaques in the brain. They are composed of aggregated amyloid beta-peptide (Aβ) misfolded into beta-sheets which are the cause of the AD memory impairment and dementia. Memory depends on the hippocampal formation and maintenance of synapses by long-term potentiation (LTP), whose main steps are the activation of NMDA receptors, the phosphorylation of CaMKIIα and the nuclear translocation of the transcription factor CREB. It is known that Aβ oligomers (oAβ) induce synaptic loss and impair the formation of new synapses. Here, we have studied the effects of oAβ on CaMKIIα. We found that oAβ produce reactive oxygen species (ROS), that induce CaMKIIα oxidation in human neuroblastoma cells as we assayed by western blot and immunofluorescence. Moreover, this oxidized isoform is significantly present in brain samples from AD patients. We found that the oxidized CaMKIIα is active independently of the binding to calcium/calmodulin, and that CaMKIIα phosphorylation is mutually exclusive with CaMKIIα oxidation as revealed by immunoprecipitation and western blot. An in silico modelling of the enzyme was also performed to demonstrate that oxidation induces an activated state of CaMKIIα. In brains from AD transgenic models of mice and in primary cultures of murine hippocampal neurons, we demonstrated that the oxidation of CaMKIIα induces the phosphorylation of CREB and its translocation to the nucleus to promote the transcription of ARC and BDNF. Our data suggests that CaMKIIα oxidation would be a pro-survival mechanism that is triggered when a noxious stimulus challenges neurons as do oAβ.
Keywords: Alzheimer’s disease, amyloid, CaMKIIα, oxidative stress, CREB
1. Introduction
Alzheimer’s disease (AD) is a neurodegenerative disease with the highest prevalence worldwide [1]. AD is a type of dementia whose main histopathological hallmarks are the presence of amyloid β-peptide (Aβ) forming extracellular senile plaques and intracellular fibrillary tangles caused by tau aggregation [2]. High concentrations of Aβ aggregate forming neurotoxic oligomers, initiating the damage in the hippocampus and causing memory loss [3,4].
The hippocampus is the centre in the brain for memory and learning based on glutamatergic neurotransmission. Glutamate released by the presynaptic terminal binds to both NMDA and AMPA receptors [5] at the postsynaptic terminal, allowing the entrance of sodium and calcium into the postsynaptic neuron. An increase in synaptic transmission will lead to a sustained calcium entry, which is necessary to induce long-term potentiation (LTP) [6]. Calcium entry will trigger an intracellular signalling initiated by the enzyme calcium/calmodulin dependent kinase IIα (CaMKIIα), that will lead to the phosphorylation and posterior nuclear translocation of the transcription factor cAMP response element-binding protein (CREB) [7]. This pathway is the main mechanism for learning and memory, promotes dendritic spine growth and is reported as being neuroprotective [8].
CaMKIIα is one of the four subtypes of CaMKII (-α, -β, -γ and -δ) [7]. CaMKIIα is a large protein (a homododecamer) activated by Ca2+/calmodulin binding, which induces its autophosphorylation. Autophosphorylation of one of the subunits facilitates Ca2+/calmodulin binding to the neighbouring units. This mechanism enables CaMKIIα to codify the intensity of calcium entry to produce different signalling outputs [9]. Furthermore, CaMKIIα autophosphorylated at T286 becomes active in a calcium-independent manner (autonomous CaMKIIα) [9]. This capacity allows for fine tuning of the intracellular signalling to regulate synaptoplasticity through CREB [7].
CaMKII has been reported to be susceptible to oxidation in cardiomyocytes resulting in pathological consequences in heart [10]. Oxidation affects methionines 281 and 282 in β-, γ- and δ-, while in CaMKIIα the oxidized residues are cysteine 280 and methionine 281. This oxidation happens only if CaMKIIα is previously activated by Ca2+/calmodulin. Once oxidized, cardiac CaMKIIα stays in a prolonged autonomous state with low kinase activity.
Since calcium entry is pathologically increased in AD due to the effect of Aβ oligomers (oAβ) on NMDA receptors [11], and oxidative stress is one the main neurotoxic mechanisms of Aβ [11,12,13], here we have aimed the study of the post-translational modifications of neuronal CaMKIIα due to oAβ and the effects on its activity.
2. Results
2.1. Oxidation Induces Autonomous CaMKIIα Activity
It was previously reported that in cardiomyocytes ROS causes the pathophysiological activation of CaMKII by its oxidation [12,13], an activation state that occurs after Ca2+/CaM binding and lasts after the release of the Ca2+/CaM (Figure 1A). Here we have studied if this oxidation occurs in the α isoform in vitro (Figure 1B–D). Firstly, we demonstrated that CaMKIIα activity is dependent on the previous binding of Ca2+/CaM, since there was no activity when Ca2+/CaM was not preincubated with the enzyme (Figure 1B). Moreover, the oxidative stress inducer H2O2 did not affect the activity of CaMKIIα when it was bound to Ca2+/CaM (Figure 1B). Then, the activated enzyme was incubated with the calcium chelator BAPTA-AM previous to any contact with ATP, demonstrating that once the enzyme was oxidized it remained active even in the absence of Ca2+ [10,14] (p < 0.05) (Figure 1C). Finally, the incubation of the enzyme with the classical CaMKIIα inhibitor Kn-93 was able to reduce native CaMKIIα activity (p < 0.001), but not the activity of oxidized CaMKIIα (Figure 1D).
2.2. Aβ Triggers CaMKIIα Oxidation
Aβ induces neuronal death mostly by oxidative stress [11,15]. Therefore, we aimed the study on the effect of oAβ1–42 on neuroblastoma cells (Figure 2). Cells were treated with oAβ1–42 or H2O2, and the production of oxidative stress was analysed by the oxidation of H2DCFDA (Figure 2A). As expected, 10 µM oAβ1–42 and 200 µM H2O2 produced statistically significant amounts of free radicals (p < 0.05 and p < 0.0001, respectively). Furthermore, we studied the toxic effect of oAβ1–42 on neuroblastoma cells by MTT reduction assay (Figure 2B). We found that 10 µM oAβ1–42 was neurotoxic after 24 h of treatment (p < 0.0001) and this toxicity was partially reverted by the CaMKIIα inhibitor Kn-93 (p < 0.05), suggesting that a prolonged activation of CaMKIIα by oAβ1–42 could have deleterious effects.
In order to study the effect of oAβ1–42 on CaMKIIα, we pre-treated SH-SY5Y cells either with or without 10 μM of the calcium chelator BAPTA-AM for 30 min, then we added either 10 μM oAβ1–42 or 200 µM H2O2, and cells were incubated for 30 min. Ox-CaMKIIα and the total CaMKIIα were studied by western blot (WB) (Figure 3). We found that both oAβ1–42 and H2O2 induce CaMKIIα oxidation (p < 0.001) (Figure 3A). The same results were obtained regarding the effect of oAβ1–42 and H2O2 on CaMKIIα oxidation when cells were studied by immunofluorescence (Figure 3B). Consistently, this oxidation was impaired when cells were pre-incubated with BAPTA-AM, which prevented the required activation by Ca2+/CaM, making it impossible to reach the autonomous state of activation (Figure 3A,B).
In order to demonstrate that within all CaMKII isoforms, the α isoform is able to become oxidized, we performed a PLA assay. This assay shows if two antigens recognized by two different antibodies (in this case anti-ox-CaMKII and anti-CaMKIIα) coexist within 50 nm, sharing a proximal location [16] (Figure 3C). Our results demonstrate that neuroblastoma cells treated with 10 μM oAβ1–42 for 30 min presented significant CaMKIIα oxidation (p < 0.001) (Figure 3C).
Once it was demonstrated that CaMKIIα is oxidized by oAβ1–42, we addressed the study of the relationship between both post-translational modifications, phosphorylation and oxidation. Cells were lysed, and phosphorylated CaMKIIα was immunoprecipitated in a proportion of 1:10 regarding the input (Figure 4). Multiple WBs were run to study the presence of total, phosphorylated and oxidized CaMKIIα, demonstrating that both modifications are mutually exclusive.
The pathophysiological relevance of these findings was assayed by the study of the CaMKIIα in AD brain samples (Figure 5). We performed immunofluorescence analysis on cortical samples from AD patients compared to samples from non-demented donors. As expected, we found a significant increase in CaMKIIα oxidation in AD brain samples compared to non-demented donors (p < 0.05).
2.3. In Silico Modelling of ox-CaMKIIα
We modelled the structure of CaMKIIα in silico and we also modelled the effect of putative mutants that mimicked the effect of the oxidation at C280 and/or M281 (Figure 6). An amplified detail of the loop shows the potential interaction between phosphorylated Thr-286 and Arg-283 in order to stabilize the helix capping (Figure 6A). We studied the effect of mutant isoforms by changing the phosphorylated and oxidized amino acids by glutamic (Figure 6B), which mimics the effect of such post-translational modifications resulting in the mutants T286E and C280E/M281E. The reliability of the prediction is scored from 0 to 9, 9 being the most reliable prediction (indicated as Conf). The prediction shows that phosphorylated T286 can help to sustain the helix (stabilization of the capping) despite extending the loop, while the oxidation of C280 and Met281 will extend the helix. We hypothesise that after oxidation of C280 and M281, the conformation of CaM-binding helix in the N-terminal domain of calmodulin-kinase will be less flexible, being more difficult to recover its original structure (Figure 6C). On the other hand, the phosphorylation of Thr286 will help to preserve the original conformation of the helix and even increase the flexibility of the hinge loop, helping to recover the original structure after the clamp of calmodulin releases the binding helix (Figure 6C).
2.4. Pathophysiological Effects of ox-CaMKIIα
The CaMKII-CREB pathway is known to be protective for neurons since CREB phosphorylation and its nuclear translocation will start the transcription of pro-survival genes [18,19]. oAβ1–42 is a well-known inducer of neuronal toxicity [20,21,22] and one of the main mechanisms of neurotoxicity is the production of oxidative stress [23,24,25], which will promote the oxidation of CaMKIIα. Consistently, we have found that transgenic mice overexpressing APPswe/PSEN1dE9 (Figure 7A) have a significant higher expression of p-CREB than the cortical samples from wild type mice (p < 0.0001). The presence of Aβ deposits in the cortex of the mice is showed in Figure S1. Therefore, we have studied the role of oAβ1–42 on CREB phosphorylation (Figure 7B). Our results demonstrated that oAβ1–42 induced a prolonged activation of CREB by its phosphorylation (p < 0.01). This effect was independent of the phosphorylation state of CaMKIIα, since the inhibitor Kn-93 did not produce effects on the levels of p-CREB (p < 0.001).
The downstream effect of CREB phosphorylation is the activation of the transcription of genes related with memory and learning and with neuronal survival [18,19]. For this reason, we have analysed by RT-PCR the transcription of ARC (Figure 8A) and BDNF (Figure 8B). In both cases (Figure 8), we found that the presence of Aß and the consequent oxidation of CaMKIIα increase the transcription of BDNF and ARC along 24 h independent of the presence of the CaMKIIα inhibitor Kn-93.
3. Discussion
Memory loss is a very early symptom of AD, which progresses to dementia. In particular, the hippocampus which is the centre of memory and learning, is dramatically affected by Aβ in AD. Therefore, we have studied the role of oAβ on the intracellular signalling that impairs memory formation. We focused our work in the post-translational modifications of CaMKIIα, the key enzyme that transmits the signal from the postsynaptic term to the soma allowing the translocation of CREB, a mechanism not just involved in memory formation but also in neuroprotection [26].
CaMKII oxidation has been studied previously in the heart, where it was found that it is pathological [10]. Consistently, we have found that CaMKIIα can be oxidized in vitro and this oxidized state of the enzyme results in permanent activity even in the absence of Ca2+. This state is termed “autonomous” since its activity becomes independent of Ca2+ once it is oxidized.
Therefore, our goal was to study of the effect of oAβ1–42 on CaMKIIα, since oxidative stress is playing a key pathophysiological role in AD [20]. oAβ1–42 is able to produce oxidative stress by itself [11,27], and here we have demonstrated that oAβ1–42 is producing free radicals that affect the cell viability of human neuroblastoma cells. The free radicals produced by oAβ1–42 oxidize CaMKIIα. This post-translational modification induces a CaMKIIα autonomous active state, like H2O2 does. The presence of ox-CaMKIIα in brain samples from AD patients show the pathophysiological relevance of the findings.
We have modelled the oxidation of CaMKIIα in silico to demonstrate that it produces the activation of the enzyme. This post-translational modification shows a different structural stability than CaMKIIα phosphorylation. As demonstrated by the structural studies that we performed, once Ca2+/CaM binds to CaMKIIα, the hinge structure that hides the catalytic domain opens. Both CM280-281 and T286 are located in the sequence that constitutes this hinge. Through CaMKIIα oxidation, this sequence becomes an α-helix, providing a structural stability that enables CaMKIIα to work in an autonomous way. Even though both CM280-281 oxidation and T286 phosphorylation stabilize the structure, they are mutually exclusive because their post-translational modifications share a common location in the α-helix. Furthermore, α-helix stability is lower in the oxidized state, which supports our enzymatic activity results. Finally, since oxidation remains for a longer time than phosphorylation, the final model depicts an ox-CaMKIIα that is mildly but constantly active compared to the phosphorylated CaMKIIα.
The capacity of sustaining an autonomous active state through phosphorylation enables CaMKIIα to change its conformational state and facilitate the phosphorylation of other monomers that constitute the physiological homododecameric CaMKIIα. This physiological effect is able to codify the intensity of neuronal activity and induce different kinds of signalling such as neuroprotection or the induction of LTP. Therefore, it is necessary to know if the effect of a pathologically driven oxidation of CaMKIIα is beneficial or detrimental for neurons. Since we found that CREB phosphorylation is increased in AD model mice and in hippocampal neurons challenged with oAβ1–42, we hypothesise that CaMKIIα oxidation would be a protective mechanism triggered by neurons after being challenged by oAβ1–42. This mechanism is a steady low active state, while phosphorylation is able to transduce potent calcium signalling [9,10,28,29]. This potent calcium signalling leads to an exponential threshold signalling necessary for the induction of LTP through phosphorylation of CREB at S133, S142 and S143 [30,31]. Thus, our results suggest a possible initial neuroprotective effect regarding the oxidative stress produced by oAβ1–42 through CaMKIIα oxidation to maintain CREB activity, which induces the transcription of genes involved in synaptic plasticity and survival such as ARC and BDNF, as we have found.
In conclusion, in this work we report the existence of CaMKIIα oxidation in AD brain samples and in neuroblastoma cells treated with oAβ1–42 as a model of AD. This oxidation generates a Ca/CaM autonomous state that may be beneficial regarding the beginning of Aβ neurotoxicity. However, due to the mutual exclusion of oxidation and physiological phosphorylation, this will lead to CaMKIIα becoming inactive. This inactivity can affect LTP and ultimately lead to neurotoxicity and cell death.
4. Material and Methods
4.1. Cell Lines
Human neuroblastoma cells (SH-SY5Y) were grown with Ham’s F12 medium plus GlutaMAX (Gibco, Waltham, MA, USA) supplemented with 15% fetal bovine serum (FBS; Biowest Nuaillé, France) and 1% penicillin/streptomycin (Gibco). Cells were incubated at 37 °C in a humidified atmosphere of 5% CO2. They were plated on 6-well plates (300,000 cells/well) for western blot (WB) studies or on 24-well plates with coverslips (90,000 cells/well) for immunofluorescence studies.
4.2. Primary Cultures of Mouse Hippocampal Neurons
Hippocampal neurons were isolated from 18-day-old CMB mouse embryos. This procedure was approved by the Ethics Committee of the Institut Municipal d’Investigacions Mèdiques-Universitat Pompeu Fabra. The hippocampi were aseptically dissected and tripsinized. Cells were seeded in DMEM high glucose (Gibco) supplemented with 10% horse serum and 1% penicillin/streptomycin into poly-D-Lysine coated plates (Gibco). After 120 min, the medium was removed and neurobasal medium (Gibco) was added containing 2% B27 supplement (Gibco), 1% penicillin/streptomycin, and 1% GlutaMAX (Gibco). On day three of culturing, cells were treated with 1.5 µM 1-ß-D-arabinofuranosylcytosine (Sigma, San Luis, MO, USA) for 24 h to eliminate proliferating non-neuronal cells. Hippocampal neurons were used for the experiments on day 15.
4.3. Human Cortical Brain Samples
Human cortical samples were supplied by the Neurological Tissue Bank of the Biobank-Hospital Clínic-IDIBAPS, Barcelona, Spain. The procedure was carried out according to the rules of the Helsinki Declaration and to the Ethics Committee of the Institut Municipal d’Investigacions Mèdiques-Universitat Pompeu Fabra (EC-IMIM-UPF). Samples were obtained from four non-demented control (two women and two men; 70 ± 0.8 years old) and three AD patient (two women and one man; 73 ± 1.8 years old).
4.4. Mouse Cortical Brain Samples
Mouse cortical brain samples were obtained from B6C3-Transgenic (APPswePSEN1ΔE9)85Dbo/J mice purchased from Jackson Laboratory (Bar Harbor, ME, USA) and wild-type mice. The procedure was carried out according to the rules of the Helsinki Declaration and to the Comité Ético Científico para el Cuidado de Animales y Ambiente (CEC-CAA) from Pontifical Catholic University of Chile. Samples were obtained from 19-month-old animals.
4.5. Aβ Preparation
1 mg of lyophilized Aβ1–42 (Anaspec, Fremont, CA, USA) was solubilized in 250 μL of sterile MiliQ water. The pH was adjusted to ≥10.5 with 1 M NaOH to avoid the isoelectric point of Aβ. Once dissolved, 250 μL of 20 mM phosphate buffer (pH 7.4) were added to the solution, followed by six 10 s-cycles of sonication (Bioruptor, Diagenode, Liège, Belgium). Finally, 2 μΛ of non-supplemented Ham’s F12 GlutaMax (Gibco) were added to the final 500 μL of disaggregated monomeric Aβ to achieve a concentration of 88.66 μM.
4.6. Aβ Oligomerization
Aliquots of monomeric Aβ were maintained at 4 °C for 24 h without agitation to allow its aggregation. After 24 h, they were frozen at −20 °C until use.
4.7. CaMKIIα Kinase Assay
CaMKIIα activity was measured by a commercial kinase activity kit (Promega, Madison, WI, USA). Briefly, 1 ng of CaMKIIα activity was assessed by the kinase ATP consumption kit (ADP-Glo Promega) and inferred from a consumption curve of 25 μM ATP/ADP at different ratios. The kinase was previously treated to induce its oxidation with 10 μM H2O2, free Ca2+ was chelated in some conditions using 2 mM BAPTA-AM (Millipore, Darmstadt, Germany) and the CaMKIIα inhibitor Kn-93 (MedChemExpress, Monmouth Junction, NJ, USA) was used at 1 μM. Then, the kit’s protocol was followed.
4.8. Reactive Oxygen Species (ROS) Production Assay
SH-SY5Y cells seeded in a 24-well plate (90,000 cells/well) were pre-incubated with 10 μM H2DCFDA (Life technologies, Carlsbad, CA, USA) in isotonic solution (140 mM NaCl, 2.5 mM KCl, 1.2 mM CaCl2, 0.5 mM MgCl2, 5 mM Glucose, 10 mM HEPES; pH 7.3–7.4 adjusted with Tris Base, osmolarity 300–310 mOsm adjusted with D-Mannitol) at 37 °C plus 5% CO2 and treated with either vehicle, 10 μM oAβ1–42 or 200 μM H2O2 for 2 h at 37 °C. Fluorescence was measured every three min at 522 nm by a VICTOR Nivo Multimade Plate Reader (PerkinElmer, Waltham, MA, USA).
4.9. MTT Reduction Assay
SH-SY5Y cells seeded in a 24-well plate (90,000 cells/well) were treated with vehicle, 1 μM Kn-93, 10 μM oAβ1–42 or a combination of both in FBS-free Ham’s F12 medium for 24 h. Then, cells were incubated with 0.5 mg/mL MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution for 2 h. Formazan crystals were solubilized in 500 μL DMSO and cell viability was determined by absorbance at 595 nm by VICTOR Nivo Multimade Plate Reader (PerkinElmer).
4.10. Study of CaMKIIα Oxidation by WB in Neuroblastoma Cells
SH-SY5Y cells (6-well plates; 300,000 cells/well) were treated with 10 μM BAPTA-AM for 1 h or with either 10 μM oAβ1–42 or 200 μM H2O2 for 30 min in Ham’s F12 medium with 1% FBS. Then, cells were lysed on ice with 50 μL of RIPA buffer (150 mM Sodium Chloride, 1.0% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 50 mM Tris, pH 8.0) supplemented with phosphatase and protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 1 mM N-ethylmaleimide and 1 mM sodium orthovanadate). Cells were scraped and the samples were centrifuged at 15,000× g for 10 min at 4 °C. Samples were loaded into NuPAGETM Bis-Tris 4–12% protein gels. Next, proteins were transferred onto 0.2 μm pore nitrocellulose membranes. Membranes were blocked for 1 h at room temperature (RT) with 5% bovine serum albumin (BSA) in Tween 20-Tris buffer solution (TTBS: 100 mM Tris-HCl, 150 mM NaCl, pH 7.5 plus 0.1% Tween-20). Then, membranes were incubated overnight (o.n.) at 4 °C with rabbit anti-oxidized CaMKII (ox-CaMKII; 1:1000; GeneTex, Irvine, CA, USA), mouse monoclonal anti-CaMKIIα (1:1000; ThermoFisher, Waltham, MA, USA) or mouse anti-GAPDH (1:2000; Abcam) antibody (Ab). Horseradish peroxidase-conjugated donkey anti-rabbit and anti-mouse Abs (GE Healthcare, Chicago, IL, USA) were used as secondary Ab at 1:2000 for 1 h at RT. Primary and secondary Ab were diluted in 5% BSA in TTBS. Bands were visualized with Clarity Western ECL Substrate (BioRad, Hercules, CA, USA) and analysed with ImageJ software (version 1.53c).
4.11. Study of CaMKIIα Oxidation by Immunofluorescence in Neuroblastoma Cells
SH-SY5Y cells (24-well plates; 90,000 cells/well) were incubated with FBS-free Ham’s F12 with or without 10 μM BAPTA-AM for 30 min. Later, cells were treated with 10 μM oAβ1–42 or 200 μM H2O2 for 30 min. Cells were fixed with 4% PFA in PBS for 15 min, permeabilized with 0.2% Triton-100X in PBS for 10 min and then blocked with 5% BSA in PBS for 30 min. Coverslips were incubated o.n. at 4 °C in a humid chamber with 1:200 rabbit anti-ox-CaMKII (GeneTex) and 1:200 goat polyclonal anti-CaMKIIα (NovusBio, Centennial, CO, USA) Abs. Coverslips were incubated with Alexa Fluor 647 donkey anti-goat Ab (1:2000; Abcam), Alexa Fluor 488 donkey anti-rabbit Ab (1:2000; Invitrogen, Waltham, MA, USA) and DAPI (1:1000) for 1 h at RT. Coverslips were mounted onto slides with Fluoromount-G (SouthernBiotech, Birmingham, AL, USA). Digital images were taken with a Leica TCS SP5 Upright confocal microscope and analysed with ImageJ software (version 1.53c).
4.12. Study of CaMKIIα Oxidation by Proximity Ligation Assay
SH-SY5Y cells (90,000 cells/well) were treated with 10 μM BAPTA-AM for 1 h and 10 μM oAβ1–42 for 30 min. Cells were fixed with 4% PFA in PBS for 15 min and then permeabilized with 0.2% Triton-100X in PBS for 10 min. After these last steps, the DuolinkR Proximity Ligation Assay (PLA) Fluorescence Protocol established by Sigma-Aldrich (St. Louis, MO, USA) was followed. Primary Abs were 1:200 rabbit anti-ox-CaMKII and 1:200 goat polyclonal anti-CaMKIIα. 1:5 secondary Abs provided by the PLA kit (Sigma-Aldrich) were donkey anti-goat PLUS and donkey anti-rabbit MINUS. Digital images were taken with a Leica TCS SP5 Upright confocal microscope and analysed with ImageJ software (version 1.53c).
4.13. Immunoprecipitation and Study of CaMKIIα Phosphorylation and Oxidation
Twenty-four hours before the protein extraction from SH-SY5Y cells, we prepared sepharose beads for immunoprecipitation. Briefly, 100 μL sepharose G beads (Fisher Scientific, Hampton, NH, USA) were washed thrice with ice-cold TBS and centrifuged in between (3000× g; 3 min). Then, the beads were incubated o.n. with 1:50 rabbit anti-ox-CaMKII Ab (GeneTex) or 1:50 anti-phosphorylated-Thr286 CaMKIIα Ab (Thermo Fisher, Waltham, MA, USA) in ice-cold TBS with protease inhibitor cocktail (Roche Basilea, Switzerland) in rotation at 4 °C. Then, the beads were centrifuged at 3000× g for 3 min and blocked with 1% BSA in TBS for 1 h in rotation at 4 °C. Beads were washed again thrice with ice-cold TBS and kept at 4 °C while the procedure was carried out.
SH-SY5Y cells seeded in a 75 cm2 flask at 80% confluence were washed twice with PBS, trypsinized for 5 min and then centrifuged at 1200 rpm for 5 min. Pellets were lysed with 700 μL of non-denaturing lysis buffer (150 mM Sodium Chloride, 1.0% TritonX-100, 50 mM Tris, pH 8.0) supplemented with phosphatase and protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 1 mM N-ethylmaleimide and 1 mM sodium orthovanadate), and centrifuged at 15,000× g for 10 min at 4 °C. 250 μL of extracted protein were added to the bead-Ab complexes and incubated in rotation for 4 h at 4 °C. Next, beads were washed again thrice with ice-cold TBS as before. To elute bead-attached proteins, 50 μL of 0.2 M glycine (pH 2–3) were added to the beads and incubated for 10 min with strong mixing at RT. Then, 50 μL of 1 M Tris-HCl (pH 7–8) were added, alongside 20 μL of loading buffer (concentrated five times). Samples were analysed by WB as described above, and samples reserved from the protein extraction were used as inputs.
4.14. Structural In Silico Modelling of CaMKIIα Oxidation
The structure of the N-terminus (Nt) domain of CaMKIIα was taken from PDB [32] (code 6W4O) and the conformation of the CaM binding helix was completed with the structure of AlphaFold2 [33] model (AF-Q9UQM7-F1_model_v3) up to residue 311. We used MODELLER [34] to model the structure of the Nt domain with the CaM binding helix bound by CaM. First, we removed the restrictions of the helix with respect to the Nt domain; then, we forced the contacts with CaM derived from the complex of a helix peptide with CaM (structure taken from PDB with code 6XXX). For the sequence of mutant T286E we used the model of the complex of the native sequence as the template, while for mutant C280E/M291E we added the restrictions of α-helix to the Nt capping (residues 280–285). PSIPRED [35] was used for the prediction of secondary structure using the full length of CaMKIIα/CaMKII.
4.15. Study of CaMKIIα Oxidation by Immunofluorescence in Human Samples
Human cortical sections (5 µm) were treated with 0.15 M glycine and 10 mg/mL NaBH4 (both in PBS) for 30 min. They were washed in deionized water, permeabilized with 0.3% Triton-100X in PBS for 1 h at 4 °C, and then blocked with 5% FBS + 1% BSA diluted in 0.1% Triton X-100 in PBS for 2 h. The following step was incubation o.n. at 4 °C with 1:200 rabbit anti-ox-CaMKII and 1:200 goat anti-CaMKIIα Abs. Samples were incubated the next day with Alexa Fluor 647 donkey anti-goat Ab (1:2000; Abcam), Alexa Fluor 488 donkey anti-rabbit Ab (1:2000; Invitrogen) and DAPI (1:1000) for 1 h at RT. They were then treated for 10 min with 4% Sudan Black (Sigma) in ethanol that was previously mixed o.n. at 4 °C, centrifuged at 3000× g for 20 min, filtered using common filter paper, washed with deionized water and mounted using Fluoromont. Digital images were taken with a Leica TCS SP8 confocal microscope and analysed with ImageJ software (version 1.53c).
4.16. Study of CREB Phosphorylation by Immunofluorescence in Murine Samples
Cortical brain samples were treated following the protocol described in Section 4.15. without using NaBH4. Then, samples were incubated o.n. at 4 °C with the primary Abs 1:400 rabbit anti-p-CREB (Cell Signaling, Danvers, MA, USA) and 1:100 mouse anti-Aβ (6E10, Covance, Princeton, NJ, USA). After washing the samples, they were incubated with Alexa Fluor 488 donkey anti-rabbit Ab (1:1000; Invitrogen), Alexa Fluor 555 donkey anti-mouse Ab (1:1000; Invitrogen) and DAPI for 1 h at RT. Digital images were taken with a Leica TCS SP5 confocal microscope and analysed with ImageJ software (version 1.53c).
4.17. Study of CREB Phosphorylation in Primary Hippocampal Neurons
Primary hippocampal neuronal culture was treated for 1 h with 100 nM oAβ1–42, 1 μM Kn-93 or a combination of both. Cells were fixed with 4% PFA in PBS for 15 min, permeabilized with 0.3% Triton-100X in PBS for 10 min and then blocked with 3% BSA in PBS for 30 min. Coverslips were incubated o.n. at 4 °C in a humid chamber with rabbit anti-pCREB (Ser133) (1:100; Cell Signaling) Ab. Coverslips were incubated with Alexa Fluor 488 donkey anti-rabbit Ab (1:2000; Invitrogen) and DAPI (1:1000) for 1 h at RT. Coverslips were mounted onto slides with Fluoromount. Digital images were taken with a Leica TCS SP5 Inverted confocal microscope and analysed with ImageJ software (version 1.53c).
4.18. Real Time PCR Analysis of Gene Transcription Due to CREB Phosphorylation
SH-SY5Y cells seeded in a 12-well plate (200,000 cells/well) were treated with either 1 μM Kn-93, 10 μM oAβ1–42 or a combination of both, in Ham’s F12 medium supplemented with 1% FBS, for 3, 6, or 24 h. Total RNA was isolated from cells using a NucleoSpin RNA isolation kit (Macherey-Nagel, Düren, Germany). SuperScript III reverse transcriptase system (Thermo Fisher Scientific) was used for complementary DNA synthesis. Quantitative real-time polymerase chain reaction was performed using SYBR Green (Applied Biosystems, Waltham, MA, USA) in a QuantStudio 12K Flex system (Applied Biosystems). GAPDH and HPRT1 were used as housekeeping genes for the quantification of relative gene expression using 2-ΔΔCt. Primers used for hCaMKIIα were commercially obtained from Sino Biological. We designed the other primers with the sequences indicated in Figure S2.
4.19. Statistical Analysis
Data are expressed as the mean ± SEM of the values from the number of experiments indicated in the corresponding figures. Student’s t-test, one-way analysis of variance (ANOVA) or two-way analysis of variance (ANOVA) plus Bonferroni as the post-hoc test were used for statistical analyses. p > 0.05 is considered not significant (ns).
Acknowledgments
We thank the Neurological Tissue Bank of the Biobank-Hospital Clínic-IDIBAPS (Barcelona, Spain) for providing the human brain samples. We also thank Marta Linares (Department of Medicine and Life Sciences, Universitat Pompeu Fabra) for her help during the procedure with the histological samples from brain mice.
Abbreviations
A.U., arbitrary units; Ab, Antibody; Aβ, amyloid β-peptide; AD, Alzheimer’s disease; AMPAR, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; BSA, bovine serum albumin; CaMKII, calcium/calmodulin-dependent kinase II; Ca2+/CaM, calcium/calmodulin complex; CREB, cAMP response element-binding protein; FBS, fetal bovine serum; H2DCFDA, dichlorofluorescein; LTP, long-term potentiation; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NMDARs, N-methyl-D-aspartate receptors; Nt, N-terminus; ns, not significant; o.n., overnight; PBS, phosphate buffer saline; PFA, paraformaldehyde, ox-CaMKIIα, oxidized CaMKIIα; PLA, proximity ligation assay; RT, room temperature; WB, western blot.
Supplementary Materials
The supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms232315169/s1.
Author Contributions
P.P.-P. and F.J.M. conceived and designed the experiments. P.P.-P., H.F.-U., V.H.-F., S.A.-B., L.G.-L., D.A.G., A.O., A.R.Á. and B.O. performed the experiments. P.P.-P., H.F.-U., V.H.-F., B.O. and F.J.M. analysed the data and drafted the manuscript. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación plus FEDER Funds through grants PID2020-117691RB-I00/AEI/10.13039/501100011033 (F.J.M.), SAF2017-83372-R (F.J.M.), BIO 2020-113203RB (B.O.) and PID2021-123482OB-I00 (A.O.). This work was also funded by the “María de Maetzu Programme” for Units of Excellence in R&D and the MM-MELIS intercollaborative projects (award CEX2018-000792-M/IPEP-MM2020-5). Funding for this project was also from the Comisión Nacional de Investigación Científica y Tecnológica-Chile: Fondecyt 12011668 (to A.R.Á.) and Millennium Science Initiative Program—ICN09_016/ICN 2021_045 (to A.R.Á.).
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Nichols E., Vos T. The estimation of the global prevalence of dementia from 1990-2019 and forecasted prevalence through 2050: An analysis for the Global Burden of Disease (GBD) study 2019. Alzheimer’s Dement. 2021;17:e051496. doi: 10.1002/alz.051496. [DOI] [Google Scholar]
- 2.Alzheimer A., Stelzmann R.A., Norman Schnitzlein H., Reed Murtagh F. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin. Anat. 1995;8:429–431. doi: 10.1002/ca.980080612. [DOI] [PubMed] [Google Scholar]
- 3.Todorov A.B., Go R.C.P., Constantinidis J., Elston R.C. Specificity of the clinical diagnosis of dementia. J. Neurol. Sci. 1975;26:81–98. doi: 10.1016/0022-510X(75)90116-1. [DOI] [PubMed] [Google Scholar]
- 4.Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., Ashe K.H. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer’s disease. J. Neurosci. 2002;22:1858–1867. doi: 10.1523/JNEUROSCI.22-05-01858.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Martin S.J., Grimwood P.D., Morris R.G.M. Synaptic Plasticity and Memory: An Evaluation of the Hypothesis. Annu. Rev. Neurosci. 2003;23:649–711. doi: 10.1146/annurev.neuro.23.1.649. [DOI] [PubMed] [Google Scholar]
- 6.Whitlock J.R., Heynen A.J., Shuler M.G., Bear M.F. Learning induces long-term potentiation in the hippocampus. Science. 2006;313:1093–1097. doi: 10.1126/science.1128134. [DOI] [PubMed] [Google Scholar]
- 7.Giese K.P. The role of CaMKII autophosphorylation for NMDA receptor-dependent synaptic potentiation. Neuropharmacology. 2021;193:108616. doi: 10.1016/j.neuropharm.2021.108616. [DOI] [PubMed] [Google Scholar]
- 8.Takeda H., Kitaoka Y., Hayashi Y., Kumai T., Munemasa Y., Fujino H., Kobayashi S., Ueno S. Calcium/calmodulin-dependent protein kinase II regulates the phosphorylation of CREB in NMDA-induced retinal neurotoxicity. Brain Res. 2007;1184:306–315. doi: 10.1016/j.brainres.2007.09.055. [DOI] [PubMed] [Google Scholar]
- 9.Coultrap S.J., Bayer K.U. CaMKII regulation in information processing and storage. Trends Neurosci. 2012;35:607–618. doi: 10.1016/j.tins.2012.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Erickson J.R., Joiner M., Ling A., Guan X., Kutschke W., Yang J., Oddis C.V., Bartlett R.K., Lowe J.S., O’Donnell S.E., et al. A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation. Cell. 2008;133:462–474. doi: 10.1016/j.cell.2008.02.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Guivernau B., Bonet J., Valls-Comamala V., Bosch-Morató M., Godoy J.A., Inestrosa N.C., Perálvarez-Marín A., Fernández-Busquets X., Andreu D., Oliva B., et al. Amyloid-β peptide nitrotyrosination stabilizes oligomers and enhances NMDAR-mediated toxicity. J. Neurosci. 2016;36:11693–11703. doi: 10.1523/JNEUROSCI.1081-16.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Taniguchi K., Yamamoto F., Amamo A., Tamaoka A., Sanjo N., Yokota T., Kametani F., Araki W. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer’s disease. Neurosci. Res. 2022;180:90–98. doi: 10.1016/j.neures.2022.03.001. [DOI] [PubMed] [Google Scholar]
- 13.Texidó L., Martín-Satué M., Alberdi E., Solsona C., Matute C. Amyloid β peptide oligomers directly activate NMDA receptors. Cell Calcium. 2011;49:184–190. doi: 10.1016/j.ceca.2011.02.001. [DOI] [PubMed] [Google Scholar]
- 14.Song Y.H. A Memory Molecule, Ca2+/Calmodulin-Dependent Protein Kinase II and Redox Stress; Key Factors for Arrhythmias in a Diseased Heart. Korean Circ. J. 2013;43:145. doi: 10.4070/kcj.2013.43.3.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Miranda S., Opazo C., Larrondo L.F., Muñoz F.J., Ruiz F., Leighton F., Inestrosa N.C. The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease. Prog. Neurobiol. 2000;62:633–648. doi: 10.1016/S0301-0082(00)00015-0. [DOI] [PubMed] [Google Scholar]
- 16.Bagchi S., Fredriksson R., Wallén-Mackenzie Å. In Situ Proximity Ligation Assay (PLA) Methods Mol. Biol. 2015;1318:149–159. doi: 10.1007/978-1-4939-2742-5_15. [DOI] [PubMed] [Google Scholar]
- 17.Segura J., Oliva B., Fernandez-Fuentes N. CAPS-DB: A structural classification of helix-capping motifs. Nucleic Acids Res. 2012;40:D479. doi: 10.1093/nar/gkr879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Motaghinejad M., Mashayekh R., Motevalian M., Safari S. The possible role of CREB-BDNF signaling pathway in neuroprotective effects of minocycline against alcohol-induced neurodegeneration: Molecular and behavioral evidences. Fundam. Clin. Pharmacol. 2021;35:113–130. doi: 10.1111/fcp.12584. [DOI] [PubMed] [Google Scholar]
- 19.Walton M., Woodgate A.M., Muravlev A., Xu R., During M.J., Dragunow M. CREB phosphorylation promotes nerve cell survival. J. Neurochem. 1999;73:1836–1842. [PubMed] [Google Scholar]
- 20.Talafous J., Marcinowski K.J., Klopman G., Zagorski M.G. Solution structure of residues 1-28 of the amyloid beta-peptide. Biochemistry. 1994;33:7788–7796. doi: 10.1021/bi00191a006. [DOI] [PubMed] [Google Scholar]
- 21.D’Ursi A.M., Armenante M.R., Guerrini R., Salvadori S., Sorrentino G., Picone D. Solution Structure of Amyloid β-Peptide (25–35) in Different Media. J. Med. Chem. 2004;47:4231–4238. doi: 10.1021/jm040773o. [DOI] [PubMed] [Google Scholar]
- 22.Balbach J.J., Petkova A.T., Oyler N.A., Antzutkin O.N., Gordon D.J., Meredith S.C., Tycko R. Supramolecular structure in full-length Alzheimer’s beta-amyloid fibrils: Evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys. J. 2002;83:1205–1216. doi: 10.1016/S0006-3495(02)75244-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wu J., Wang A., Min Z., Xiong Y., Yan Q., Zhang J., Xu J., Zhang S. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo. Biochem. Biophys. Res. Commun. 2011;408:382–387. doi: 10.1016/j.bbrc.2011.04.013. [DOI] [PubMed] [Google Scholar]
- 24.Parajuli B., Sonobe Y., Horiuchi H., Takeuchi H., Mizuno T., Suzumura A. Oligomeric amyloid β induces IL-1β processing via production of ROS: Implication in Alzheimer’s disease. Cell Death Dis. 2013;4:e975. doi: 10.1038/cddis.2013.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Muche A., Arendt T., Schliebs R. Oxidative stress affects processing of amyloid precursor protein in vascular endothelial cells. PLoS ONE. 2017;12:e0178127. doi: 10.1371/journal.pone.0178127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sakamoto K., Karelina K., Obrietan K. CREB: A multifaceted regulator of neuronal plasticity and protection. J. Neurochem. 2011;116:1. doi: 10.1111/j.1471-4159.2010.07080.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ill-Raga G., Ramos-Fernández E., Guix F.X., Tajes M., Bosch-Morató M., Palomer E., Godoy J., Belmar S., Cerpa W., Simpkins J.W., et al. Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells. J. Alzheimer’s Dis. 2010;22:641–652. doi: 10.3233/JAD-2010-100474. [DOI] [PubMed] [Google Scholar]
- 28.Shi T., Yang Y., Zhang Z., Zhang L., Song J., Ping Y., Du X., Song G., Liu Q., Li N. Loss of MsrB1 perturbs spatial learning and long-term potentiation/long-term depression in mice. Neurobiol. Learn. Mem. 2019;166:107104. doi: 10.1016/j.nlm.2019.107104. [DOI] [PubMed] [Google Scholar]
- 29.Coultrap S.J., Bayer K.U. Nitric Oxide Induces Ca2+-independent Activity of the Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) J. Biol. Chem. 2014;289:19458–19465. doi: 10.1074/jbc.M114.558254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sun P., Enslen H., Myung P.S., Maurer R.A. Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 1994;8:2527–2539. doi: 10.1101/gad.8.21.2527. [DOI] [PubMed] [Google Scholar]
- 31.Pulimood N.S., Contreras M., Pruitt M.E., Tarasiewicz A., Medina A.E. Phosphorylation of CREB at Serine 142 and 143 Is Essential for Visual Cortex Plasticity. eNeuro. 2021;8:ENEURO.0217-21.2021. doi: 10.1523/ENEURO.0217-21.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Burley S.K., Bhikadiya C., Bi C., Bittrich S., Chen L., Crichlow G.V., Duarte J.M., Dutta S., Fayazi M., Feng Z., et al. RCSB Protein Data Bank: Celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D. Protein Sci. 2022;31:187–208. doi: 10.1002/pro.4213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Jumper J., Hassabis D. Protein structure predictions to atomic accuracy with AlphaFold. Nat. Methods. 2022;19:11–12. doi: 10.1038/s41592-021-01362-6. [DOI] [PubMed] [Google Scholar]
- 34.Webb B., Sali A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinform. 2016;2016:5.6.1–5.6.37. doi: 10.1002/cpbi.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Buchan D.W.A., Jones D.T. The PSIPRED Protein Analysis Workbench: 20 years on. Nucleic Acids Res. 2019;47:W402–W407. doi: 10.1093/nar/gkz297. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Not applicable.